[EN] Alzheimer's disease was first described in 1907 by Alois Alzheimer. It is a progressive neurological disorder with a gradual onset of dementia. Although Alzheimer's was initially a rare disease, it is now one of the most common diseases in the elderly and is the fourth most common cause of death in this age group in the rankings. In this paper, we present a new methods of group intelligence to improve image threshold in Alzheimer's diagnosis. The challenge of this method is the uncertainty of metaheuristic methods in solving optimization problem
One of the current challenges in the field of Alzheimer's disease (AD) is to identify patients with ...
Brain pathological changes linked with Alzheimer's disease (AD) can be measured with Neuroimaging. I...
The use of positron emission tomography (PET) as the initial or sole biomarker of β-amyloid (Aβ) bra...
Recent research in computational engineering have evidenced the design and development numerous inte...
Alzheimer's disease is currently the most common kind of senile dementia. With the increasing aging ...
[EN] Alzheimer's disease is a dangerous and progressive disease that affects the nervous system and ...
Alzheimer’s is one of the fast-growing diseases among people worldwide leading to brain atrophy. Neu...
This work presents the creation of classifiers able to automatically diagnose Alzheimer’s disease fr...
The method of diagnosing and treating diseases can be improved by identifying the genes that cause d...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects a large number of people across...
Alzheimer’s is a chronic neurodegenerative disease developed due to multiple cognitive deficits that...
Abstract: In current times the level at which Alzheimer’s disease is rising is at an alarming rate. ...
Alzheimer’s disease (AD) is a neurodegenerative illness and is considered one of the main causes of ...
Alzheimer's disease is a multifactorial and progressive neurodegenerative disorder that \ud affects ...
There has been a steady rise in the number of patients suffering from Alzheimer’s disease (AD) all ...
One of the current challenges in the field of Alzheimer's disease (AD) is to identify patients with ...
Brain pathological changes linked with Alzheimer's disease (AD) can be measured with Neuroimaging. I...
The use of positron emission tomography (PET) as the initial or sole biomarker of β-amyloid (Aβ) bra...
Recent research in computational engineering have evidenced the design and development numerous inte...
Alzheimer's disease is currently the most common kind of senile dementia. With the increasing aging ...
[EN] Alzheimer's disease is a dangerous and progressive disease that affects the nervous system and ...
Alzheimer’s is one of the fast-growing diseases among people worldwide leading to brain atrophy. Neu...
This work presents the creation of classifiers able to automatically diagnose Alzheimer’s disease fr...
The method of diagnosing and treating diseases can be improved by identifying the genes that cause d...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects a large number of people across...
Alzheimer’s is a chronic neurodegenerative disease developed due to multiple cognitive deficits that...
Abstract: In current times the level at which Alzheimer’s disease is rising is at an alarming rate. ...
Alzheimer’s disease (AD) is a neurodegenerative illness and is considered one of the main causes of ...
Alzheimer's disease is a multifactorial and progressive neurodegenerative disorder that \ud affects ...
There has been a steady rise in the number of patients suffering from Alzheimer’s disease (AD) all ...
One of the current challenges in the field of Alzheimer's disease (AD) is to identify patients with ...
Brain pathological changes linked with Alzheimer's disease (AD) can be measured with Neuroimaging. I...
The use of positron emission tomography (PET) as the initial or sole biomarker of β-amyloid (Aβ) bra...